President Trump unveiled “The Great Healthcare Plan” on January 15, 2026, calling on Congress to reduce prescription drug prices, lower insurance premiums, and increase healthcare price transparency. The plan proposes four main components: codifying Most-Favored-Nation (MFN) drug pricing agreements that the administration has negotiated with 16 pharmaceutical manufacturers, targeting prices at the lowest international levels;Redirecting…
The Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofi’s Neuro Pipeline Expands to…
Atrium spun out of Avidity Biosciences, which Novartis acquired in a $12 billion deal. The Atrium pipeline is led by two RNA therapies with a path to the clinic for rare inherited cardiological disorders that have no FDA-approved drugs. The post Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions appeared first…
Merck has been acquiring assets that could help make up for the coming revenue decline as its top product, the cancer drug Keytruda, drops off the patent cliff. Terns Pharmaceuticals’ lead product candidate, in development for treating a type of leukemia, could offer dosing and efficacy advantages over the Novartis drug Scemblix. The post Merck’s…
The number of people receiving treatment at the National Institutes of Health Clinical Center — the renowned research hospital that cares for patients with rare or life-threatening diseases — has tumbled under the second Trump administration, according to government documents and interviews with current and former NIH employees. NIH documents viewed by KFF Health News…
Ochsner Health is expanding its use of Latent Health’s AI platform after its reduced medication prior authorization times to just 4-5 minutes. The technology is designed to both streamline pharmacists’ workflows as well as improve patients’ access to medications. The post Ochsner Health Scales AI Tool After Its Cuts Prior Authorization Time to Just 4-5…
Nearly 90% of babies who had to be hospitalized with covid-19 had mothers who didn’t get the vaccine while they were pregnant, according to new data released by the Centers for Disease Control and Prevention. The findings appear in the agency’s Morbidity and Mortality Weekly Report. Babies too young to be vaccinated had the highest…
Emerging evidence suggests that combining these interventions may enhance treatment outcomes and provide options for patients who have not responded to traditional therapies. The post Combining Ketamine and Deep TMS: A New Frontier in Treating Depression appeared first on MedCity News.
Pete Hudson is one of the OGs of digital health. As an emergency room doc he was fed up with his friends bothering him with their medical problems and he created a tool called iTriage, which helped patients figure out what condition they had, and where to go to deal with it. This was fifteen…
Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday November 14 at 1PM PT 4PM ET. Today we have also a special guest – former Permanente Medical Group CEO Dr Robbie Pearl @robertpearlmd. Robbie has been diving into AI in his latest book ChatGPT-MD and we’ll be chatting about that as well as his forecasts for health…